Chat with us

Social Media Marketing for Pharma Companies

Build a credible pharma brand online, from disease awareness and healthcare professional engagement to OTC campaigns and employer branding, with medical and legal review built into every post.

  • Disease Awareness
  • HCP Engagement
  • OTC & Wellness
  • LinkedIn
  • Medical-Legal Review

For pharmaceutical manufacturers, OTC and consumer health brands, nutraceutical companies, API and CDMO businesses and distributors across India. For hospitals and clinics, see healthcare social media marketing.

Ch. 02 — Why pharma is different

Why social media marketing for pharma needs a different playbook

Pharma can’t market like a consumer brand. Prescription medicines cannot be promoted to the public in India, and promotion to healthcare professionals is governed by the Uniform Code for Pharmaceutical Marketing Practices, 2024.

That doesn’t mean pharma has to stay off social media. Companies can run unbranded disease awareness, share corporate and research news, build an employer brand, engage healthcare professionals with scientific content through appropriate channels, and market OTC, nutraceutical and wellness products within advertising standards.

The difference is process. Every post needs medical and legal review, comments must be monitored for adverse event mentions, and different audiences need separate accounts or clear boundaries.

  • No Rx promotion to the publicPrescription brands stay out of consumer posts.
  • Awareness is not advertisingDisease education must not point to a product.
  • Medical-legal reviewNothing is published without sign-off.
  • Adverse event monitoringSide-effect mentions are routed to pharmacovigilance.
  • Long approval cyclesCalendars are planned weeks ahead.
  • Many audiencesHCPs, patients, trade, investors and talent need different content.
Ch. 03 — Content workflow

How a pharma post goes live, safely.

Our workflow is built around your review process, not the other way round.

  1. Brief
    What happens
    Audience, objective and the approved claims or references to use.
    Who owns it
    Your brand team with us
  2. Draft
    What happens
    Copy, visuals and references prepared, with sources attached.
    Who owns it
    UpSocially
  3. Medical review
    What happens
    Scientific accuracy and fair balance checked.
    Who owns it
    Your medical team
  4. Legal & regulatory
    What happens
    Checked against UCPMP 2024 and advertising law.
    Who owns it
    Your legal or regulatory team
  5. Publish & monitor
    What happens
    Posted, moderated, and adverse events escalated within agreed timelines.
    Who owns it
    UpSocially, with your PV team

Audit trailEvery post keeps its approval record, so you can show who signed off what and when.

Ch. 04 — Services

Pharma social media marketing services

Our social media marketing for pharma companies is organised by audience, with a separate content plan and approval route for each.

Unbranded disease awareness

Campaigns that help people recognise symptoms and seek medical advice, without naming or pointing to a product.

SupportsPublic health and category growth.

HCP engagement on LinkedIn

Scientific updates, CME and conference announcements and medical affairs content for healthcare professionals.

SupportsCredibility with prescribers.

OTC, nutraceutical & wellness campaigns

Consumer campaigns for products that can be advertised, within ASCI’s healthcare guidelines.

SupportsBrand demand where it is permitted.

Corporate & employer branding

Company news, manufacturing quality, CSR and hiring content for LinkedIn and Instagram.

SupportsTalent and investor confidence.

Social listening & adverse event monitoring

Monitoring comments and mentions, and routing possible adverse events to your pharmacovigilance team.

SupportsCompliance and early warning.

Community management

Moderation and replies using pre-approved responses, with escalation for medical questions.

SupportsSafe, consistent conversations.

B2B marketing for API & CDMO

LinkedIn content and campaigns aimed at procurement and R&D teams at other pharma companies.

SupportsExport and partnership enquiries.

Reporting

Monthly reporting by audience: reach, engagement, enquiries and approval turnaround.

SupportsKnowing what works. See attribution & analytics.

Ch. 05 — Who it's for

Pharma businesses we work with

The plan depends on what you make and who you sell to.

Manufacturers

Pharma manufacturers

Branded generics and specialty products. Priority: corporate brand, HCP engagement and disease awareness.

Consumer health

OTC & consumer health brands

Products that can be advertised. Priority: consumer campaigns within ASCI guidelines.

Wellness

Nutraceutical & wellness

Supplements and wellness ranges. Priority: education-led content without disease claims.

B2B

API & CDMO companies

Selling to other pharma companies. Priority: LinkedIn, capability content and trade-show campaigns. See our manufacturing marketing approach.

Distribution

Pharma distributors

Trade relationships. Priority: availability, partnerships and recruitment.

Devices

Medical device companies

Different rules again. See medical device marketing.

Ch. 06 — Audiences

Which audience, which channel

We plan channels and content by audience, with clear boundaries between them.

AudienceMain channelsWhat we create
Doctors & HCPsLinkedIn, medical affairs channelsScientific updates, CME and conference news
Patients & publicInstagram, Facebook, YouTubeUnbranded disease awareness and healthy living
OTC & wellness buyersInstagram, YouTube, Meta adsProduct campaigns where advertising is permitted
Pharmacists & tradeLinkedIn, WhatsApp communitiesAvailability, partnerships and trade news
Talent & investorsLinkedInCulture, quality, hiring and company milestones
Ch. 07 — Compliance

Medical, legal and regulatory review on every post

Nothing goes live without your medical and legal sign-off, and any comment mentioning a side effect reaches your pharmacovigilance team.

We work within the Uniform Code for Pharmaceutical Marketing Practices 2024, the Drugs and Magic Remedies Act, the Drugs and Cosmetics rules on advertising and ASCI’s healthcare guidelines. We are a marketing agency, not a regulatory consultancy, so your regulatory team remains the final authority on every claim.

Ch. 08 — Process

How we work with pharma teams

  1. Discovery

    Portfolio, audiences, markets and existing approvals.

  2. Audit

    Current accounts, content and risks.

  3. Governance

    Account structure, approval routes and escalation rules.

  4. Content plan

    Quarterly calendar by audience.

  5. Approvals

    Medical, legal and regulatory review of each batch.

  6. Publishing

    Scheduling and moderation with approved responses.

  7. Listening

    Monitoring and adverse event routing.

  8. Report & improve

    Monthly reporting by audience.

Ch. 09 — Reporting

What we measure

Success looks different for each audience, so we report on each separately.

Good social media marketing for pharma is measured by credibility with professionals, awareness with the public and enquiries from partners, not by follower counts alone.

  • HCP reach on LinkedIn
  • Awareness campaign reach
  • Engagement by audience
  • Partnership and export enquiries
  • Job applications
  • Approval turnaround time
  • Adverse events routed
  • Sentiment
Ch. 10 — FAQs

Frequently asked questions

How does social media marketing for pharma work in India?

Pharma companies use social media for unbranded disease awareness, corporate and employer branding, scientific engagement with healthcare professionals and, for OTC and wellness products, consumer campaigns. Prescription medicines cannot be promoted to the public, so every post needs medical and legal review.

Read the full answer →
Can pharma companies advertise on Instagram and Facebook?

They can run unbranded awareness, corporate and OTC or wellness campaigns, subject to Meta’s policies and Indian advertising rules. Prescription brands should not be advertised to the public. Ads must avoid disease claims and targeting based on health conditions.

Read the full answer →
What happens if someone reports a side effect in a comment?

A comment that mentions a possible side effect may need to be reported to the company’s pharmacovigilance team. Your agency should monitor comments, use pre-approved responses and escalate such mentions within agreed timelines.

Read the full answer →
Does UCPMP 2024 apply to pharma social media?

Yes. The Uniform Code for Pharmaceutical Marketing Practices, 2024 governs how companies promote medicines to healthcare professionals, and its principles apply to digital and social channels. Claims must be accurate, balanced and capable of substantiation, and your regulatory team should review content.

Read the full answer →
Is LinkedIn useful for pharma companies?

Yes. LinkedIn suits scientific updates, conference and CME announcements, corporate news, B2B marketing for API and CDMO businesses, and hiring. It reaches doctors, partners, investors and talent without consumer-facing promotion.

Read the full answer →
How long does pharma social media content take to approve?

It depends on your medical, legal and regulatory review process. Many teams need one to three weeks per batch. Planning a monthly or quarterly calendar ahead and sending content in batches keeps posting consistent despite long review cycles.

Read the full answer →

More answers in our healthcare and pharma marketing FAQs.

Ch. 11 — Free review

Get a free pharma social media review

Tell us about your portfolio and audiences. We’ll review your current accounts and suggest a compliant plan for social media marketing for pharma that your review teams can work with.

  • Which audiences to prioritise
  • Account structure and approval workflow
  • Content you can publish safely

Request my review

We reply within one working day (Mon–Fri, 10 AM–7 PM IST). Your details stay confidential.

Request received ✓

Thanks — we'll review and get back within one working day. Want to talk sooner? WhatsApp us.

Chat with us